Overview of Clinical Trials on Type 2 Diabetes Mellitus: A Comprehensive Analysis of the ClinicalTrials.gov Database

References

• Cho NH , Shaw JE , Karuranga S , et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract . 2018;138:271–281. doi:10.1016/j.diabres.2018.02.023 29496507
   PubMed Web of Science ®Google Scholar
• Holman N , Young B , Gadsby R . Current prevalence of type 1 and type 2 diabetes in adults and children in the UK. Diabet Med . 2015;32(9):1119–1120. doi:10.1111/dme.12791 25962518
   PubMed Web of Science ®Google Scholar
• GBD DALYs, HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet . 2016;388(10053):1603–1658. doi:10.1016/S0140-6736(16)31460-X.27733283
   PubMed Web of Science ®Google Scholar
• Stumvoll M , Goldstein BJ , van Haeften TW . Type 2 diabetes: principles of pathogenesis and therapy. Lancet . 2005;365(9467):1333–1346. doi:10.1016/S0140-6736(05)61032-X 15823385
   PubMed Web of Science ®Google Scholar
• Yang Q , Graham TE , Mody N , et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature . 2005;436(7049):356–362. doi:10.1038/nature03711 16034410
   PubMed Web of Science ®Google Scholar
• Marcheva B , Ramsey KM , Buhr ED , et al. Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature . 2010;466(7306):627–631. doi:10.1038/nature09253 20562852
   PubMed Web of Science ®Google Scholar
• Samuel VT , Shulman GI . Mechanisms for insulin resistance: common threads and missing links. Cell . 2012;148(5):852–871. doi:10.1016/j.cell.2012.02.017 22385956
   PubMed Web of Science ®Google Scholar
• Mata-Cases M , Rodriguez-Sanchez B , Mauricio D , et al. The association between poor glycemic control and health care costs in people with diabetes: a population-based study. Diabetes Care . 2020;43(4):751–758. doi:10.2337/dc19-0573 32029636
   PubMed Web of Science ®Google Scholar
• Satirapoj B , Pratipanawatr T , Ongphiphadhanakul B , Suwanwalaikorn S , Benjasuratwong Y , Nitiyanant W . Real-world evaluation of glycemic control and hypoglycemic events among type 2 diabetes mellitus study (REEDS): a multicentre, cross-sectional study in Thailand. BMJ Open . 2020;10(2):e031612. doi:10.1136/bmjopen-2019-031612
   Web of Science ®Google Scholar
• Stolar M . Glycemic control and complications in type 2 diabetes mellitus. Am J Med . 2010;123(Suppl 3):S3–S11. doi:10.1016/j.amjmed.2009.12.004 20206730
   PubMed Web of Science ®Google Scholar
• De Angelis C , Drazen JM , Frizelle FA , et al. Clinical trial registration: a statement from the international committee of medical journal editors. N Engl J Med . 2004;351(12):1250–1251. doi:10.1056/NEJMe048225 15356289
   PubMed Web of Science ®Google Scholar
• Hartung DM , Zarin DA , Guise JM , McDonagh M , Paynter R , Helfand M . Reporting discrepancies between the ClinicalTrials.gov results database and peer-reviewed publications. Ann Intern Med . 2014;160(7):477–483. doi:10.7326/M13-0480 24687070
   PubMed Web of Science ®Google Scholar
• Zwierzyna M , Davies M , Hingorani AD , Hunter J . Clinical trial design and dissemination: comprehensive analysis of clinicaltrials.gov and PubMed data since 2005. BMJ . 2018;361:k2130. doi:10.1136/bmj.k2130 29875212
   PubMed Web of Science ®Google Scholar
• Anderson ML , Chiswell K , Peterson ED , Tasneem A , Topping J , Califf RM . Compliance with results reporting at ClinicalTrials.gov. N Engl J Med . 2015;372(11):1031–1039. doi:10.1056/NEJMsa1409364 25760355
   PubMed Web of Science ®Google Scholar
• Califf RM , Zarin DA , Kramer JM , Sherman RE , Aberle LH , Tasneem A . Characteristics of clinical trials registered in ClinicalTrials.gov, 2007–2010. JAMA . 2012;307(17):1838–1847. doi:10.1001/jama.2012.3424 22550198
   PubMed Web of Science ®Google Scholar
• Buffel DVC , Dechartres A , Battin C , Ravaud P , Boutron I . Exclusion of patients with concomitant chronic conditions in ongoing randomised controlled trials targeting 10 common chronic conditions and registered at ClinicalTrials.gov: a systematic review of registration details. BMJ Open . 2016;6(9):e012265. doi:10.1136/bmjopen-2016-012265
   Web of Science ®Google Scholar
• De Angelis CD , Drazen JM , Frizelle FA , et al. Is this clinical trial fully registered? A statement from the international committee of medical journal editors. Ann Intern Med . 2005;143(2):146–148. doi:10.7326/0003-4819-143-2-200507190-00016 16027458
   PubMed Web of Science ®Google Scholar
• Zarin DA , Tse T , Williams RJ , Rajakannan T . Update on trial registration 11 years after the ICMJE policy was established. N Engl J Med . 2017;376(4):383–391. doi:10.1056/NEJMsr1601330 28121511
   PubMed Web of Science ®Google Scholar
• Bull RI , Petersen SS , Juel J , Hansen MR , Andersen NH , Pareek M . Novel antidiabetic drugs and cardiovascular complications. Ugeskr Laeger . 2018;180(26).
   Google Scholar
• Kumar P , Larrison C , Rodrigues SB , McKeithen T . Assessment of general practitioners’ needs and barriers in primary health care delivery in Asia Pacific region. J Family Med Prim Care . 2019;8(3):1106–1111. doi:10.4103/jfmpc.jfmpc_46_19 31041258
   PubMedGoogle Scholar
• Tham TY , Tran TL , Prueksaritanond S , Isidro JS , Setia S , Welluppillai V . Integrated health care systems in Asia: an urgent necessity. Clin Interv Aging . 2018;13:2527–2538. doi:10.2147/CIA.S185048 30587945
   PubMed Web of Science ®Google Scholar
• Wood L , Egger M , Gluud LL , et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ . 2008;336(7644):601–605. doi:10.1136/bmj.39465.451748 18316340
   PubMed Web of Science ®Google Scholar
• Tahrani AA , Bailey CJ , Del PS , Barnett AH . Management of type 2 diabetes: new and future developments in treatment. Lancet . 2011;378(9786):182–197. doi:10.1016/S0140-6736(11)60207-9 21705062
   PubMed Web of Science ®Google Scholar
• Rocha S , Ribeiro D , Fernandes E , Freitas MA . Systematic review on anti-diabetic properties of chalcones. Curr Med Chem . 2020;27(14):2257–2321. doi:10.2174/0929867325666181001112226 30277140
   PubMed Web of Science ®Google Scholar
• Nissen SE , Wolski K . Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med . 2007;356(24):2457–2471. doi:10.1056/NEJMoa072761 17517853
   PubMed Web of Science ®Google Scholar
• Hillaire-Buys D , Faillie JL , Montastruc JL . Pioglitazone and bladder cancer. Lancet . 2011;378(9802):1543–1545. doi:10.1016/S0140-6736(11)61662-0
   PubMed Web of Science ®Google Scholar
• Deedwania P , Acharya T . Cardiovascular protection with anti-hyperglycemic agents. Am J Cardiovasc Drugs . 2019;19(3):249–257. doi:10.1007/s40256-019-00325-9 30767126
   PubMed Web of Science ®Google Scholar
• El MC , Riachy R , Khalil AB , Eid A , Azar S . SGLT2 inhibitors, GLP-1 agonists, and DPP-4 inhibitors in diabetes and microvascular complications: a review. Int J Endocrinol . 2020;2020:1762164. doi:10.1155/2020/1762164 32190049
   PubMed Web of Science ®Google Scholar
• Fonseca VA , Kirkman MS , Darsow T , Ratner RE . The American diabetes association diabetes research perspective. Diabetes Care . 2012;35(6):1380–1387. doi:10.2337/dc12-9001 22619289
   PubMed Web of Science ®Google Scholar
• Alberti KG , Zimmet P , Shaw J . International diabetes federation: a consensus on type 2 diabetes prevention. Diabet Med . 2007;24(5):451–463. doi:10.1111/j.1464-5491.2007.02157.x 17470191
   PubMed Web of Science ®Google Scholar
• Gong Q , Zhang P , Wang J , et al. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing diabetes prevention outcome study. Lancet Diabetes Endocrinol . 2019;7(6):452–461. doi:10.1016/S2213-8587(19)30093-2 31036503
   PubMed Web of Science ®Google Scholar
• Jiang L , Johnson A , Pratte K , Beals J , Bullock A , Manson SM . Long-term outcomes of lifestyle intervention to prevent diabetes in American Indian and Alaska native communities: the special diabetes program for Indians diabetes prevention program. Diabetes Care . 2018;41(7):1462–1470. doi:10.2337/dc17-2685 29915128
   PubMed Web of Science ®Google Scholar
• Hill-Briggs F . 2018 Health care & education presidential address: the American diabetes association in the era of health care transformation. Diabetes Care . 2019;42(3):352–358. doi:10.2337/dci18-0051 30787058
   PubMed Web of Science ®Google Scholar
• Dutton GR , Lewis CE . The look AHEAD trial: implications for lifestyle intervention in type 2 diabetes mellitus. Prog Cardiovasc Dis . 2015;58(1):69–75. doi:10.1016/j.pcad.2015.04.002 25936906
   PubMed Web of Science ®Google Scholar
• Lakey WC , Barnard K , Batch BC , Chiswell K , Tasneem A , Green JB . Are current clinical trials in diabetes addressing important issues in diabetes care? Diabetologia . 2013;56(6):1226–1235. doi:10.1007/s00125-013-2890-4 23564296
   PubMed Web of Science ®Google Scholar
• Ross JS , Tse T , Zarin DA , Xu H , Zhou L , Krumholz HM . Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis. BMJ . 2012;344(jan03 1):d7292. doi:10.1136/bmj.d7292 22214755
   PubMed Web of Science ®Google Scholar
• Hirsch L . Trial registration and results disclosure: impact of US legislation on sponsors, investigators, and medical journal editors. Curr Med Res Opin . 2008;24(6):1683–1689. doi:10.1185/03007990802114849 18462565
   PubMed Web of Science ®Google Scholar
• Zarin DA , Tse T , Williams RJ , Carr S . Trial reporting in ClinicalTrials.gov - the final rule. N Engl J Med . 2016;375(20):1998–2004. doi:10.1056/NEJMsr1611785 27635471
   PubMed Web of Science ®Google Scholar
• Liu X , Li Y , Jiang L , et al. To promote good research practice, good publication practice and good translation by implementing research ethic and publication ethic–the explanation document for the second statement of Chinese clinical trial registration and publication collaboration[Chinese]. Chin J Evid Based Med . 2011;11(07):726–732.
   Google Scholar
• Taichman DB , Sahni P , Pinborg A , et al. Data sharing statements for clinical trials - a requirement of the international committee of medical journal editors. N Engl J Med . 2017;376(23):2277–2279. doi:10.1056/NEJMe1705439 28581902
   PubMed Web of Science ®Google Scholar
• Ross JS , Mulvey GK , Hines EM , Nissen SE , Krumholz HM . Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis. PLoS Med . 2009;6(9):e1000144. doi:10.1371/journal.pmed.1000144 19901971
   PubMed Web of Science ®Google Scholar
• Decullier E , Lheritier V , Chapuis F . Fate of biomedical research protocols and publication bias in France: retrospective cohort study. BMJ . 2005;331(7507):19. doi:10.1136/bmj.38488.385995.8F 15967761
   PubMed Web of Science ®Google Scholar
• Blumenthal D , Campbell EG , Anderson MS , Causino N , Louis KS . Withholding research results in academic life science. Evidence from a national survey of faculty. JAMA . 1997;277(15):1224–1228. doi:10.1001/jama.277.15.1224 9103347
   PubMed Web of Science ®Google Scholar